Vipin Mehta, MD

Professional activities:

• Teaching adult and pediatric cardiac anesthesiology subjects to residents and fellows
• Teaching adult and pediatric cardiac trans esophageal echocardiography to residents and fellows
• Teaching pediatric cardiac post-surgical patient care to PICU fellows
• Participate in teaching and giving lectures in topics related to pediatric and adult cardiac anesthesia in national conferences in India; give talks on similar topics in various institutes and university hospitals in India and Ghana, Africa.
• Part of Children's Hospital Pediatric Cardiac surgical team to manage patients with congenital heart disease, pre-, per- and post-operatively and help them eventually to start pediatric cardiac institute, first in West Africa
• Involved in administrative activities in day to day working in pediatric cardiac subdivision of cardiac anesthesiology at Massachusetts General Hospital.

Research:

• Co-investigator in randomized, double-blind, placebo-controlled, multi-center study to evaluate the cardioprotective effects of MC-1 in patients undergoing high risk CABG surgery, 2006.
• Worked as co-investigator in Primo CABG trial II competed in April 2006.
• Worked as a principal investigator in phase III trial of Pexelizumab in November 2003, Massachusetts General Hospital, 2002-2003.
• 2002-2003: Principal investigator in phase 3 trial of Pexelizumab. Massachusetts General Hospital.
• 2006: Co-investigator. Randomized, double blinded, placebo controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high risk CABG surgery.
• April 2006: Co-investigator in completed Primo CABG trial II.